Insulin-like growth factor binding protein-6 delays replicative senescence of human fibroblasts

Mechanisms of Ageing and Development

Volumn 132, Issue 10, 2011, Pages 468-479

  Micutkova, Lucia ^a   Diener, Thomas ^a   Li, Chen ^b   Rogowska Wrzesinska, Adelina ^c   Mueck, Christoph ^a   Huetter, Eveline ^a   Weinberger, Birgit ^a   Grubeck Loebenstein, Beatrix ^a   Roepstorff, Peter ^c   Zeng, Rong ^b   Jansen Duerr, Pidder ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Fibroblast; IGFBP 6; Proteomics; Secretome; Senescence

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 6;

APOPTOSIS; ARTICLE; CELL AGING; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SENESCENCE;

ADULT; AGED; AGING; AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; CELL AGING; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DNA PRIMERS; DOWN-REGULATION; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; MOLECULAR SEQUENCE DATA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 81155159806     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2011.07.005     Document Type: Article

References (72)

1. Acosta J.C., O'Loghlen A., Banito A., Guijarro M.V., Augert A., Raguz S., Fumagalli M., Da Costa M., Brown C., Popov N., Takatsu Y., Melamed J., d'Adda di Fagagna F., Bernard D., Hernando E., Gil J. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008, 133:1006-1018.
2. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
3. Bach L.A. Insulin-like growth factor binding protein-6: the "forgotten" binding protein?. Horm. Metab. Res. 1999, 31:226-234.
4. Bach L.A. IGFBP-6 five years on; not so 'forgotten'?. Growth Horm. IGF Res. 2005, 15:185-192.
5. Bartke A. Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology 2005, 146:3718-3723.
6. Beilharz E.J., Russo V.C., Butler G., Baker N.L., Connor B., Sirimanne E.S., Dragunow M., Werther G.A., Gluckman P.D., Williams C.E., Scheepens A. Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res. Mol. Brain Res. 1998, 59:119-134.
7. Brown J.P., Wei W., Sedivy J.M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997, 277:831-834.
8. Callister S.J., Barry R.C., Adkins J.N., Johnson E.T., Qian W.J., Webb-Robertson B.J., Smith R.D., Lipton M.S. Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. J. Proteome Res. 2006, 5:277-286.
9. Campisi J. The role of cellular senescence in skin aging. J. Investig. Dermatol. Symp. Proc. 1998, 3:1-5.
10. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8:729-740.
11. Chambery D., de Galle B., Babajko S. Retinoic acid stimulates IGF binding protein (IGFBP)-6 and depresses IGFBP-2 and IGFBP-4 in SK-N-SH human neuroblastoma cells. J. Endocrinol. 1998, 159:227-232.
12. Chang B.D., Watanabe K., Broude E.V., Fang J., Poole J.C., Kalinichenko T.V., Roninson I.B. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:4291-4296.
13. Chang B.D., Swift M.E., Shen M., Fang J., Broude E.V., Roninson I.B. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:389-394.
14. Chen J., Goligorsky M.S. Premature senescence of endothelial cells: Methusaleh's dilemma. Am. J. Physiol.: Heart Circ. Physiol. 2006, 290:H1729-H1739.
15. Coppe J.P., Patil C.K., Rodier F., Sun Y., Munoz D.P., Goldstein J., Nelson P.S., Desprez P.Y., Campisi J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008, 6:2853-2868.
16. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., Smith J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:9363-9367.
17. Evtimova V., Zeillinger R., Weidle U.H. Identification of genes associated with the invasive status of human mammary carcinoma cell lines by transcriptional profiling. Tumour Biol. 2003, 24:189-198.
18. Ewton D.Z., Florini J.R. IGF binding proteins-4, -5 and -6 may play specialized roles during L6 myoblast proliferation and differentiation. J. Endocrinol. 1995, 144:539-553.
19. Ferber A., Chang C., Sell C., Ptasznik A., Cristofalo V.J., Hubbard K., Ozer H.L., Adamo M., Roberts C.T., LeRoith D., Dumenil G., Baserg R. Failure of senescent human fibroblasts to express the insulin-like growth factor-1 gene. J. Biol. Chem. 1993, 268:17883-17888.
20. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 2002, 23:824-854.
21. Fu P., Thompson J.A., Bach L.A. Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6. J. Biol. Chem. 2007, 282:22298-22306.
22. Fu P., Liang G.J., Khot S.S., Phan R., Bach L.A. Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration. J. Cell. Physiol. 2010, 224:636-643.
23. Gallicchio M.A., Kneen M., Hall C., Scott A.M., Bach L.A. Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo. Int. J. Cancer 2001, 94:645-651.
24. Goldstein S., Moerman E.J., Jones R.A., Baxter R.C. Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:9680-9684.
25. Gong J., Ammanamanchi S., Ko T.C., Brattain M.G. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Cancer Res. 2003, 63:3340-3346.
26. Gramolini A.O., Kislinger T., Alikhani-Koopaei R., Fong V., Thompson N.J., Isserlin R., Sharma P., Oudit G.Y., Trivieri M.G., Fagan A., Kannan A., Higgins D.G., Huedig H., Hess G., Arab S., Seidman J.G., Seidman C.E., Frey B., Perry M., Backx P.H., Liu P.P., MacLennan D.H., Emili A. Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Mol. Cell. Proteomics 2008, 7:519-533.
27. Grellier P., De Galle B., Babajko S. Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth. Cancer Res. 1998, 58:1670-1676.
28. Grigoriev V.G., Moerman E.J., Goldstein S. Overexpression of insulin-like growth factor binding protein-3 by senescent human fibroblasts: attenuation of the mitogenic response to IGF-I. Exp. Cell Res. 1995, 219:315-321.
29. Guan J., Williams C.E., Skinner S.J., Mallard E.C., Gluckman P.D. The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins. Endocrinology 1996, 137:893-898.
30. Hammarberg H., Risling M., Hokfelt T., Cullheim S., Piehl F. Expression of insulin-like growth factors and corresponding binding proteins (IGFBP 1-6) in rat spinal cord and peripheral nerve after axonal injuries. J. Comp. Neurol. 1998, 400:57-72.
31. Hampel B., Malisan F., Niederegger H., Testi R., Jansen-Durr P. Differential regulation of apoptotic cell death in senescent human cells. Exp. Gerontol. 2004, 39:1713-1721.
32. Hampel B., Wagner M., Teis D., Zwerschke W., Huber L., Jansen-Durr P. Apoptosis resistance of senescent human fibroblasts is correlated with the absence of nuclear IGFBP-3. Aging Cell 2005, 4:325-330.
33. Hampel B., Fortschegger K., Ressler S., Chang M.W., Unterluggauer H., Breitwieser A., Sommergruber W., Fitzky B., Lepperdinger G., Jansen-Durr P., Voglauer R., Grillari J. Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescence. Exp. Gerontol. 2006, 41:474-481.
34. Han J., Jogie-Brahim S., Harada A., Oh Y. Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-κB signaling. Cancer Lett. 2011, [Epub ahead of print].
35. Herbig U., Ferreira M., Condel L., Carey D., Sedivy J.M. Cellular senescence in aging primates. Science 2006, 311:1257.
36. Iosef C., Gkourasas T., Jia C.Y., Li S.S., Han V.K. A functional nuclear localization signal in insulin-like growth factor binding protein-6 mediates its nuclear import. Endocrinology 2008, 149:1214-1226.
37. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 1995, 16:3-34.
38. Kim E.J., Schaffer B.S., Kang Y.H., Macdonald R.G., Park J.H. Decreased production of insulin-like growth factor-binding protein (IGFBP)-6 by transfection of colon cancer cells with an antisense IGFBP-6 cDNA construct leads to stimulation of cell proliferation. J. Gastroenterol. Hepatol. 2002, 17:563-570.
39. Kim K.S., Kim M.S., Seu Y.B., Chung H.Y., Kim J.H., Kim J.R. Regulation of replicative senescence by insulin-like growth factor-binding protein 3 in human umbilical vein endothelial cells. Aging Cell 2007, 6:535-545.
40. Kim K.S., Seu Y.B., Baek S.H., Kim M.J., Kim K.J., Kim J.H., Kim J.R. Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol. Biol. Cell 2007, 18:4543-4552.
41. Krizhanovsky V., Yon M., Dickins R.A., Hearn S., Simon J., Miething C., Yee H., Zender L., Lowe S.W. Senescence of activated stellate cells limits liver fibrosis. Cell 2008, 134:657-667.
42. Kuilman T., Peeper D.S. Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 2009, 9:81-94.
43. Kulaeva O.I., Draghici S., Tang L., Kraniak J.M., Land S.J., Tainsky M.A. Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene 2003, 22:4118-4127.
44. Kuo Y.S., Tang Y.B., Lu T.Y., Wu H.C., Lin C.T. IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis through regulating EGR-1 expression. J. Pathol. 2010, 222:299-309.
45. Laschober G.T., Ruli D., Hofer E., Muck C., Carmona-Gutierrez D., Ring J., Hutter E., Ruckenstuhl C., Micutkova L., Brunauer R., Jamnig A., Trimmel D., Herndler-Brandstetter D., Brunner S., Zenzmaier C., Sampson N., Breitenbach M., Frohlich K.U., Grubeck-Loebenstein B., Berger P., Wieser M., Grillari-Voglauer R., Thallinger G.G., Grillari J., Trajanoski Z., Madeo F., Lepperdinger G., Jansen-Durr P. Identification of evolutionarily conserved genetic regulators of cellular aging. Aging Cell 2010, 9:1084-1097.
46. Li X.S., Rishi A.K., Shao Z.M., Dawson M.I., Jong L., Shroot B., Reichert U., Ordonez J., Fontana J.A. Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells. Cancer Res. 1996, 56:5055-5062.
47. Lipinski R.J., Cook C.H., Barnett D.H., Gipp J.J., Peterson R.E., Bushman W. Sonic hedgehog signaling regulates the expression of insulin-like growth factor binding protein-6 during fetal prostate development. Dev. Dyn. 2005, 233:829-836.
48. Liu B., Lee H.Y., Weinzimer S.A., Powell D.R., Clifford J.L., Kurie J.M., Cohen P. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J. Biol. Chem. 2000, 275:33607-33613.
49. Maier J.A., Voulalas P., Roeder D., Maciag T. Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science 1990, 249:1570-1574.
50. McConnell B.B., Starborg M., Brookes S., Peters G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol. 1998, 8:351-354.
51. Medcalf A.S., Klein-Szanto A.J., Cristofalo V.J. Expression of p21 is not required for senescence of human fibroblasts. Cancer Res. 1996, 56:4582-4585.
52. Moerman E.J., Thweatt R., Moerman A.M., Jones R.A., Goldstein S. Insulin-like growth factor binding protein-3 is overexpressed in senescent and quiescent human fibroblasts. Exp. Gerontol. 1993, 28:361-370.
53. Muck C., Micutkova L., Zwerschke W., Jansen-Durr P. Role of insulin-like growth factor binding protein-3 in human umbilical vein endothelial cell senescence. Rejuvenation Res. 2008, 11:449-453.
54. Naeve G.S., Vana A.M., Eggold J.R., Verge G., Ling N., Foster A.C. Expression of rat insulin-like growth factor binding protein-6 in the brain, spinal cord, and sensory ganglia. Brain Res. Mol. Brain Res. 2000, 75:185-197.
55. Ressler S., Bartkova J., Niederegger H., Bartek J., Scharffetter-Kochanek K., Jansen-Durr P., Wlaschek M. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 2006, 5:379-389.
56. Rincon M., Rudin E., Barzilai N. The insulin/IGF-1 signaling in mammals and its relevance to human longevity. Exp. Gerontol. 2005, 40:873-877.
57. Roghani M., Hossenlopp P., Lepage P., Balland A., Binoux M. Isolation from human cerebrospinal fluid of a new insulin-like growth factor-binding protein with a selective affinity for IGF-II. FEBS Lett. 1989, 255:253-258.
58. Roghani M., Segovia B., Whitechurch O., Binoux M. Purification from human cerebrospinal fluid of insulin-like growth factor binding proteins (IGFBPs). Isolation of IGFBP-2, an altered form of IGFBP-3 and a new IGFBP species. Growth Regul. 1991, 1:125-130.
59. Schedlich L.J., Le Page S.L., Firth S.M., Briggs L.J., Jans D.A., Baxter R.C. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit. J. Biol. Chem. 2000, 275:23462-23470.
60. Schedlich L.J., O'Han M.K., Leong G.M., Baxter R.C. Insulin-like growth factor binding protein-3 prevents retinoid receptor heterodimerization: implications for retinoic acid-sensitivity in human breast cancer cells. Biochem. Biophys. Res. Commun. 2004, 314:83-88.
61. Schmid C., Keller C., Gosteli-Peter M., Zapf J. Mitogenic and antiapoptotic effects of insulin-like growth factor binding protein-6 in the human osteoblastic osteosarcoma cell line Saos-2/B-10. Biochem. Biophys. Res. Commun. 1999, 263:786-789.
62. Tang L.Y., Deng N., Wang L.S., Dai J., Wang Z.L., Jiang X.S., Li S.J., Li L., Sheng Q.H., Wu D.Q., Zeng R. Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network: indicating the involvement of ribonucleoside-diphosphate reductase M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal transduction. Mol. Cell. Proteomics 2007, 6:1952-1967.
63. Toussaint O., Royer V., Salmon M., Remacle J. Stress-induced premature senescence and tissue ageing. Biochem. Pharmacol. 2002, 64:1007-1009.
64. Vasile E., Tomita Y., Brown L.F., Kocher O., Dvorak H.F. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 2001, 15:458-466.
65. Wajapeyee N., Serra R.W., Zhu X., Mahalingam M., Green M.R. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008, 132:363-374.
66. Wessel D., Flugge U.I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 1984, 138:141-143.
67. Williams A.C., Smartt H., Am H.Z., Macfarlane M., Paraskeva C., Collard T.J. Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. Cell Death Differ. 2007, 14:137-145.
68. Xie L., Tsaprailis G., Chen Q.M. Proteomic identification of insulin-like growth factor-binding protein-6 induced by sublethal H2O2 stress from human diploid fibroblasts. Mol. Cell. Proteomics 2005, 4:1273-1283.
69. Xu X.F., Guo C.Y., Liu J., Yang W.J., Xia Y.J., Xu L., Yu Y.C., Wang X.P. Gli1 maintains cell survival by up-regulating IGFBP6 and Bcl-2 through promoter regions in parallel manner in pancreatic cancer cells. J. Carcinog. 2009, 8:13.
70. Yamada P.M., Lee K.W. Perspectives in Mammalian IGFBP-3 biology: local vs. systemic action. Am. J. Physiol.: Cell Physiol. 2009, 296:C954-C976.
71. Yasuoka H., Jukic D.M., Zhou Z., Choi A.M., Feghali-Bostwick C.A. Insulin-like growth factor binding protein 5 induces skin fibrosis: a novel murine model for dermal fibrosis. Arthritis Rheum. 2006, 54:3001-3010.
72. Yoon J.W., Kita Y., Frank D.J., Majewski R.R., Konicek B.A., Nobrega M.A., Jacob H., Walterhouse D., Iannaccone P. Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J. Biol. Chem. 2002, 277:5548-5555.